아이케어 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 구입 방법별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Eye Care Market Summary

The global eye care market size was estimated at USD 22.0 billion in 2025 and is projected to reach USD 28.8 billion by 2033, growing at a CAGR of 3.4% from 2026 to 2033. The market is driven by a rising number of people suffering from eye-related disorders, an aging population, technological advancements, and increasing awareness about eye care.

The increasing prevalence of vision disorders, particularly vision impairment and presbyopia, presents a significant opportunity for the industry. With around 2.2 billion people worldwide suffering from vision impairment, and an estimated 1.09 billion cases of presbyopia affecting the middle-aged to elderly population, the demand for vision care services and products is poised to grow. The primary causes of vision impairment such as refractive errors and cataracts are largely preventable or treatable, indicating a vast untapped market for corrective lenses, surgical procedures, and other interventions. The economic burden of vision impairment, estimated at USD 411 billion annually in lost productivity, underscores the importance of accessible and affordable care solutions. The WHO's SPECS 2030 initiative aims to increase access to refractive error services by 40%, further highlighting the industry's potential. Given the demographic shifts towards an aging population and the rising awareness of eye health, the industry is well-positioned for growth, driven by the need to address the global vision disorder epidemic.

Cataract surgery is the number one surgery performed globally, with 28 million procedures each year. But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia.

Jacqueline Henderson, President Vision, EMEA, Johnson & Johnson

Technological advancements in vision care, including smart contact lenses, drug-delivering contact lenses, multifocal and extended depth of focus (EDOF) intraocular lenses (IOLs), automated refraction systems, and digital retinal imaging, represent significant drivers for the industry. These innovations enhance the functionality and efficacy of products, as well as treat and manage ocular health. For instance, smart contact lenses promise to revolutionize diabetes management by enabling continuous glucose monitoring, while drug-delivering contact lenses offer a novel approach to treating ocular surface diseases. Multifocal and EDOF IOLs improve post-cataract surgery outcomes by providing clearer vision at various distances, reducing dependency on reading glasses. For instance, in June 2023, Novaliq announced FDA approval of VEVYE (Cyclosporine Ophthalmic Solution) 0.1% for treating dry eye disease signs and symptoms, marking the first cyclosporine solution with proven efficacy in 4 weeks. In addition, in February 2024, Johnson & Johnson MedTech launched the TECNIS PureSee presbyopia-correcting intraocular lens in EMEA. This next-generation lens features a purely refractive design, delivering uninterrupted, high-quality vision with excellent low-light performance and minimal visual symptoms, enhancing cataract surgery outcomes for patients and surgeons. In addition, automated refraction systems streamline the prescription process, and digital retinal imaging aids during early detection and monitoring of diseases. These advancements drive the market forward by addressing unmet needs, and opening new markets, thereby fostering innovation and growth in the sector.

"We are starting the new year with the launch of another complex high-value product, which will help drive our continued growth, ophthalmic products represent a less crowded and more durable category, and we continue to expand our portfolio of affordable medicines."

" Andy Boyer, Executive Vice President, Chief Commercial Officer - Generics. "

Government initiatives involving the Vision and Eye Health Surveillance System (VEHSS) have driven advancements in the industry since its inception. VEHSS has evolved to include additional years of data, condition-specific composite estimates for vision impairment, blindness, and age-related macular degeneration, along with mapping and other data visualization capabilities. In 2022, VEHSS expanded its capabilities to stratify American Community Survey estimates of vision impairment and blindness by social determinants of health, including poverty, unemployment, and other disabilities.

This initiative has resulted in numerous peer-reviewed publications and reports, highlighting its impact on understanding, and addressing vision loss and conditions in the U.S. In addition, rising public health initiatives and a focus on preventive healthcare are making people more aware of the importance of regular eye exams. In May 2024, The Canadian Association of Optometrists (CAO) launched a nationwide digital campaign to remind people about the importance of eye health. This campaign, supported by provincial optometry groups, encourages Canadians to schedule regular eye exams with their optometrist.

Global Eye Care Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global eye care market report based on product, mode of purchase, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Contact Lens
• Intraocular Lens
• Ocular Health Products
• Others
• Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
• Over-The-Counter (OTC) Products
• Prescribed (Rx) Products
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Retail Stores
• Online Stores
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Mode of Purchase
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Mode of purchase outlook
  • 2.2.3. Distribution Channel outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Eye Care Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising awareness towards the importance of eye health and safety
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Rising geriatric population
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Technological limitations
• 3.3. Eye Care Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Eye Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Eye Care Market: Product Movement Analysis
• 4.3. Eye Care Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Contact Lens
  • 4.5.1. Contact Lens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Intraocular Lens
  • 4.6.1. Intraocular Lens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Ocular Health Products
  • 4.7.1. Ocular Health Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Eye Care Market: Mode of Purchase Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Eye Care Market: Mode of Purchase Movement Analysis
• 5.3. Eye Care Market by Mode of Purchase Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Over-The-Counter (OTC) Products
  • 5.5.1. Over-The-Counter (OTC) Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Prescribed (Rx) Products
  • 5.6.1. Prescribed (Rx) Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Eye Care Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Eye Care Market: Distribution Channel Movement Analysis
• 6.3. Eye Care Market by Distribution Channel Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals & Clinics
  • 6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Retail Stores
  • 6.6.1. Retail Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Online Stores
  • 6.7.1. Online Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Eye Care Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Eye Care Market movement analysis
• 7.3. Eye Care Market: Regional Estimates & Trend Analysis by Technology & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Eye Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Alcon, Inc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Johnson and Johnson Eye Care, Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Bausch & Lomb Incorporated
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Carl Zeiss Meditec AG (ZEISS International)
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Essilor International
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. CooperVision
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. HOYA CORPORATION
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Rayner
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. STAAR SURGICAL
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Novartis AG
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives